The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

Demis Hassabis, a childhood chess prodigy, said his experience with the game afforded him his first brush with AI. He was ...

It was a bold choice to host a preview screening of The Thinking Game, a documentary about AI company Google DeepMind and its ...

The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...

The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.

Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...

Google’s AI arm led by Demis Hassabis makes it harder for its researchers to publish studies in major change in approach ...

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...

Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...

Lilly and Novartis have collectively pledged almost $3 billion to their partnerships with Isomorphic signed last year, which ...

AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...